Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, Paul M, Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto, Antonio M., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter +6 more·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0807646

Cited by (1,053)

Items 201–300 of 1,053

  1. Integrative Medicine and Patient-Centered Care
    Victoria H. Maizes, David P. Rakel, Catherine Niemiec · 2009 · EXPLORE
  2. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases
    Yingyi Luan, Yong-ming Yao · 2018 · Frontiers in Immunology
  3. Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
    Amir Qaseem, Stephan D. Fihn, Sankey Williams, Paul Dallas, Douglas K Owens, Paul Shekelle · 2012 · Annals of Internal Medicine
  4. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
    US Preventive Services Task Force, Carol M. Mangione, Michael J. Barry, Wanda Kay Nicholson, Michael D. Cabana, David P. Chelmow, Tumaini R. Coker, Esa M. Davis, Katrina E Donahue, Carlos Roberto Jaén et al. · 2022 · JAMA
  5. A prospective evaluation of the directionality of the depression–inflammation relationship
    Stewart, Jesse C., Rand, Kevin L., Muldoon, Matthew F., Kamarck, Thomas W. · 2009 · Brain, Behavior, and Immunity
  6. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
    Swerdlow, Daniel I, Kuchenbaecker, Karoline B, Shah, Sonia, Sofat, Reecha, Holmes, Michael V, White, Jon, Mindell, Jennifer S, Kivimaki, Mika, Brunner, Eric J, Whittaker, John C et al. · 2016 · International Journal of Epidemiology
  7. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
    Yaron Arbel, Ariel Finkelstein, Amir Halkin, Edo Y. Birati, Miri Revivo, Meital Elbaz Zuzut, Ayala Shevach, Shlomo A. Berliner, Itzhak Herz, Gad Keren et al. · 2012 · Atherosclerosis
  8. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
    Jesper Eugen‐Olsen, Ove Andersen, Allan R Linneberg, Steen Ladelund, Tine W. Hansen, Anne Langkilde, Janne Petersen, Tomasz Pielak, L. N. Møller, Jørgen Jeppesen et al. · 2010 · Journal of Internal Medicine
  9. Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
    Mark Helfand, David Buckley, Michele Freeman, Rongwei F. Fu, Kevin R. Rogers, Craig Fleming, Linda L. Humphrey · 2009 · Annals of Internal Medicine
  10. Gender differences in cardiovascular disease
    Zujie Gao, Zengsheng Chen, Anqiang Sun, Xiaoyan Deng · 2019 · Medicine in Novel Technology and Devices
  11. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    Donald M. Lloyd‐Jones, Pamela Bowe Morris, Christie Mitchell Ballantyne, Kim K. Birtcher, David D. Daly, Sondra M. DePalma, Margo Minissian, Carl E. Orringer, Sidney C. Smith · 2017 · Journal of the American College of Cardiology
  12. Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
    Eithne Margaret Maguire, Stuart W. A. Pearce, Qingzhong Xiao · 2018 · Vascular Pharmacology
  13. Lipid-reduction variability and antidrug-antibody formation with bococizumab
    Ridker, Paul M, Tardif, Jean-Claude, Amarenco, Pierre, Duggan, William, Glynn, Robert J., Jukema, J. Wouter, Kastelein, John J.P., Kim, Albert M., Koenig, Wolfgang, Nissen, Steven et al. · 2017 · New England Journal of Medicine
  14. Cancer and systemic inflammation: treat the tumour and treat the host
    Campbell S.D. Roxburgh, Donald C. McMillan · 2014 · British Journal of Cancer
  15. Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
    Everett, Brendan M., Pradhan, Aruna D., Solomon, Daniel H., Paynter, Nina, MacFadyen, Jean, Zaharris, Elaine, Gupta, Milan, Clearfield, Michael, Libby, Peter, Hasan, Ahmed A.K. et al. · 2013 · American Heart Journal
  16. Novel Lipid Mediators Promote Resolution of Acute Inflammation
    Matthew R. Spite, Charles Nicholas Serhan · 2010 · Circulation Research
  17. Integrated safety in tocilizumab clinical trials
    M. Schiff, J. Kremer, A. Jahreis, E. Vernon, J. Isaacs, R. van Vollenhoven · 2011 · Arthritis Research & Therapy
  18. Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
    Neil Ruparelia, Joshua T. Chai, Edward A A Fisher, Robin P. Choudhury · 2017 · Nature Reviews Cardiology
  19. The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials
    Nicholas H. Adamstein, Jean G. MacFadyen, Lynda M. Rose, Robert J. Glynn, Amit Kumar Dey, Peter Libby, Ira A. Tabas, Nehal N. Mehta, Paul M. Ridker · 2020 · European Heart Journal
  20. Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Palmer, Suetonia C., Craig, Jonathan C., Navaneethan, Sankar D., Tonelli, Marcello, Pellegrini, Fabio, Strippoli, Giovanni F.M. · 2012 · Annals of Internal Medicine
  21. Inflammatory biomarkers in coronary artery disease
    Epaminondas G. Zakynthinos, Nikolitsa Pappa · 2009 · Journal of Cardiology
  22. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., Edwards, C. J. · 2010 · Rheumatology
  23. The Role of Triglycerides in Atherosclerosis
    Beatriz Talayero, Frank M. Sacks · 2011 · Current Cardiology Reports
  24. Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth
    Prabhakaran Balagopal, Sarah D. de Ferranti, Stephen Cook, Stephen R. Daniels, Samuel S. Gidding, Laura Lucia Hayman, Brian W. McCrindle, Michele Mietus‐Snyder, Julia Steinberger · 2011 · Circulation
  25. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
    Leslie Cho, Melinda Baughman Davis, Islam Y. Elgendy, Kelly Epps, Kathryn J. Lindley, Puja K. Mehta, Erin D. Michos, Margo Minissian, Carl J. Pepine, Viola Vaccarino et al. · 2020 · Journal of the American College of Cardiology
  26. Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management
    Olin, Jeffrey W., Sealove, Brett A. · 2010 · Mayo Clinic Proceedings
  27. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based
    Massimo Fioranelli, Anna Giulia Bottaccioli, Francesco Bottaccioli, Maria Bianchi, Miriam Rovesti, Maria Grazia Roccia · 2018 · Frontiers in Immunology
  28. Mechanisms of thrombosis in obesity
    Ilya O. Blokhin, Steven R. Lentz · 2013 · Current Opinion in Hematology
  29. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
    Scott M. Grundy · 2013 · Journal of clinical lipidology
  30. Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke
    Matthias Endres, María Ángeles Moro, Christian Hans Nolte, Claudia Dames, Marion S. Buckwalter, Andreas Meisel · 2022 · Circulation Research
  31. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
    Philip Greenland, Joseph S. Alpert, George Beller, Emelia J. Benjamin, Matthew Jay Budoff, Zahi Adel Fayad, Elyse Foster, Mark Andrew Hlatky, John McB. Hodgson, Frederick G. Kushner et al. · 2010 · Circulation
  32. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
    Michael Joseph Blaha, Matthew Jay Budoff, Andrew Paul DeFilippis, Ron Blankstein, Juan J. Rivera, Arthur S. Agatston, Daniel H. O’Leary, João A.C. Lima, Roger Scott Blumenthal, Khurram Nasir · 2011 · The Lancet
  33. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT
    Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer A., Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene · 2015 · Circulation
  34. Critical roles of inflammation in atherosclerosis
    Junji Moriya · 2018 · Journal of Cardiology
  35. Immune suppression and immune activation in depression
    Blume, Joshua, Douglas, Steven D., Evans, Dwight L. · 2011 · Brain, Behavior, and Immunity
  36. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials
    Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., Briel, M. · 2011 · QJM
  37. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
    2016 · The Lancet Diabetes & Endocrinology
  38. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
    Donath, Marc Y., Dalmas, Élise, Sauter, Nadine S., Böni-Schnetzler, Marianne · 2013 · Cell Metabolism
  39. C-reactive protein and the biology of disease
    Waliza Ansar, Shyamasree Ghosh · 2013 · Immunologic Research
  40. Statistical methods for assessment of added usefulness of new biomarkers
    Michael J. Pencina, Ralph B. D’Agostino, Ramachandran Srini Vasan · 2010 · Clinical Chemistry and Laboratory Medicine (CCLM)
  41. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
    Suetonia C. Palmer, Sankar Dass Navaneethan, Jonathan C. Craig, David Wayne Johnson, Vlado Perkovic, Jörgen Hegbrant, Giovanni FM Strippoli · 2014 · Cochrane Database of Systematic Reviews
  42. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
    Peter Stenvinkel · 2010 · Journal of Internal Medicine
  43. Chronic Coronary Artery Disease: Diagnosis and Management
    Andrew Cassar, David R. Holmes, Charanjit S. Rihal, Bernard John Gersh · 2009 · Mayo Clinic Proceedings
  44. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
    Scott M. Grundy, Hidenori Arai, Philip J. Barter, Thomas P. Bersot, D. J. Betteridge, Rafael Carmena, Ada M. Cuevas, Michael H. Davidson, Jacques J. Genest, Y. Antero Kesäniemi et al. · 2013 · Journal of clinical lipidology
  45. Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia
    Samia Mora, Robert J. Glynn, Judith A. Hsia, Jean G. MacFadyen, Jacques J. Genest, Paul M. Ridker · 2010 · Circulation
  46. Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study
    Sune Fallgaard Nielsen, Børge Grønne Nordestgaard · 2015 · European Heart Journal
  47. Perioperative Rosuvastatin in Cardiac Surgery
    Zheng, Zhe, Jayaram, Raja, Jiang, Lixin, Emberson, Jonathan, Zhao, Yan, Li, Qi, Du, Juan, Guarguagli, Silvia, Hill, Michael, Chen, Zhengming et al. · 2016 · New England Journal of Medicine
  48. Statin-induced myopathy: a review and update
    Thura T. Abd, Terry A. Jacobson · 2011 · Expert Opinion on Drug Safety
  49. Inflammation in Atherosclerosis—No Longer a Theory
    Peter Libby · 2020 · Clinical Chemistry
  50. Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose
    Ralph A. DeFronzo, Muhammad A Abdul‐Ghani · 2011 · The American Journal of Cardiology
  51. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults
    Tené T. Lewis, Allison E. Aiello, Sue E. Leurgans, Jeremiah Kelly, Lisa Laverne Barnes · 2009 · Brain Behavior and Immunity
  52. Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation
    K. Lentine, Salvatore P. Costa, M. Weir, J. Robb, L. Fleisher, B. Kasiske, R. Carithers, M. Ragosta, K. Bolton, Andrew D. Auerbach et al. · 2012 · Journal of the American College of Cardiology
  53. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
    Henna Cederberg, Alena Stančáková, Nagendra Yaluri, Shalem Raju Modi, Johanna Kuusisto, Markku Laakso · 2015 · Diabetologia
  54. Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
    Di Sciascio, Germano, Patti, Giuseppe, Pasceri, Vincenzo, Gaspardone, Achille, Colonna, Giuseppe, Montinaro, Antonio · 2009 · Journal of the American College of Cardiology
  55. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy
    Koenig, Wolfgang · 2013 · International Journal of Cardiology
  56. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
    Taher Mandviwala, Umair Khalid, Anita M Deswal · 2016 · Current Atherosclerosis Reports
  57. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
    Timpson, N J, Nordestgaard, B G, Harbord, R M, Zacho, J, Frayling, T M, Tybjærg-Hansen, A, Davey Smith, G · 2011 · International Journal of Obesity
  58. Statins in the primary prevention of cardiovascular disease
    Željko Reiner · 2013 · Nature Reviews Cardiology
  59. Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation
    Ádám Dénes, Peter Thornton, Nancy Jane Rothwell, Stuart McRae Allan · 2009 · Brain Behavior and Immunity
  60. Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
    Eliano Pio Navarese, Antonino Buffon, Felicita Andreotti, Marek Koziński, Nicky J. Welton, Tomasz Fabiszak, Salvatore Caputo, Grzegorz Grześk, Aldona Kubica, Iwona Świątkiewicz et al. · 2013 · The American Journal of Cardiology
  61. Anti-inflammatory therapeutics for the treatment of atherosclerosis
    Israel F. Charo, Rebecca A. Taub · 2011 · Nature Reviews Drug Discovery
  62. Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
    Ron Cornelis Hoogeveen, Christie Mitchell Ballantyne · 2020 · Clinical Chemistry
  63. A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
    Wadhera, Rishi K., Steen, Dylan L., Khan, Irfan, Giugliano, Robert P., Foody, JoAnne M. · 2016 · Journal of Clinical Lipidology
  64. Statins for the primary prevention of cardiovascular disease
    Fiona C. Taylor, Kirsten J. Ward, Theresa HM Moore, Margaret Burke, George Davey Smith, Juan Pablo Casas, Shah B J Ebrahim · 2011 · Cochrane Database of Systematic Reviews
  65. Are Curcuminoids Effective C-Reactive Protein-Lowering Agents in Clinical Practice? Evidence from a Meta-Analysis
    Amirhossein Sahebkar · 2013 · Phytotherapy Research
  66. Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
    Jashin J. Wu, Kwun‐Yee T. Poon, Jennifer C. Channual, Albert Yuh‐Jer Shen · 2012 · Archives of Dermatology
  67. Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis
    Chasman, Daniel I., Paré, Guillaume, Mora, Samia, Hopewell, Jemma C., Peloso, Gina, Clarke, Robert, Cupples, L. Adrienne, Hamsten, Anders, Kathiresan, Sekar, Mälarstig, Anders et al. · 2009 · PLoS Genetics
  68. Competing risks and the clinical community: irrelevance or ignorance?
    Michael T Koller, Heike Raatz, Ewout Willem Steyerberg, Marcel Wolbers · 2011 · Statistics in Medicine
  69. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
    Kaivan Vaidya, Clare Gabrielle Arnott, Gonzalo J. Martínez, Bernard Ng, Samuel R. McCormack, DAVID R. SULLIVAN, David Stephen Celermajer, Sanjay Patel · 2017 · JACC. Cardiovascular imaging
  70. The role of leukocytes in thrombosis
    Laura L. Swystun, Patricia C. Liaw · 2016 · Blood
  71. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study
    Kenneth Chan, Elizabeth Wahome, Apostolos Tsiachristas, Alexios S. Antonopoulos, Parijat Patel, Maria Lyasheva, Lucy Kingham, Henry W. West, Evangelos K. Oikonomou, Lucrezia Volpe et al. · 2024 · The Lancet
  72. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
    Chapman, M. J., Le Goff, W., Guerin, M., Kontush, A. · 2010 · European Heart Journal
  73. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
    Daniel H. Solomon, Joel M. Kremer, Jeffrey R. Curtis, Marc C. Hochberg, George W Reed, Peter Tsao, Michael E. Farkouh, Soko Setoguchi, Jeffrey D. Greenberg · 2010 · Annals of the Rheumatic Diseases
  74. Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials
    McKinney, James S., Kostis, William J. · 2012 · Stroke
  75. Testicular Cancer Survivorship: Research Strategies and Recommendations
    Lois B. Travis, C. Beard, James M. Allan, Alv Andreas Dahl, Darren Richard Feldman, Jan Oldenburg, Gedske Daugaard, Jennifer L. Kelly, M. Eileen Dolan, Robyn E. Hannigan et al. · 2010 · JNCI Journal of the National Cancer Institute
  76. Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease
    Toshimitsu Nozaki, Seigo Sugiyama, Hidenobu Koga, Koichi Sugamura, Keisuke Ohba, Yasushi Matsuzawa, Hitoshi Sumida, Kunihiko Matsui, Hideaki Jinnouchi, Hisao Ogawa · 2009 · Journal of the American College of Cardiology
  77. Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
    Thomas J. Wang · 2011 · Circulation
  78. Ischemic stroke in the elderly: an overview of evidence
    Ruo Li Chen, Joyce Saleh Balami, Margaret M. Esiri, Liang‐Kung Chen, Alastair Mitchell Buchan · 2010 · Nature Reviews Neurology
  79. Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
    Chasman, Daniel I., Giulianini, Franco, MacFadyen, Jean, Barratt, Bryan J., Nyberg, Fredrik, Ridker, Paul M · 2012 · Circulation: Cardiovascular Genetics
  80. Human C-reactive protein and the metabolic syndrome
    Sridevi Devaraj, Uma Shankar Singh, Ishwarlal Jialal · 2009 · Current Opinion in Lipidology
  81. From Focal Lipid Storage to Systemic Inflammation
    Peter Libby, Göran K. Hansson · 2019 · Journal of the American College of Cardiology
  82. Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
    Joe M. Chehade, Margaret Gladysz, Arshag D. Mooradian · 2013 · Drugs
  83. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
    Ali Abid, Ola Taha, William Nseir, Raymond E Farah, Maria Grosovski, Nimer Assy · 2009 · Journal of Hepatology
  84. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
    Chou, Roger, Cantor, Amy, Dana, Tracy, Wagner, Jesse, Ahmed, Azrah Y., Fu, Rongwei, Ferencik, Maros · 2022 · JAMA
  85. Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
    Konstantinos C. Koskinas, Stephan Windecker, Giovanni Pedrazzini, Christian Eugen Mueller, Stéphane Cook, Christian M. Matter, Olivier Müller, Jonas Dominik Häner, Bariş Gencer, Carmela Crljenica et al. · 2019 · Journal of the American College of Cardiology
  86. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
    Charles C. Esenwa, Mitchell S.V. Elkind · 2016 · Nature Reviews Neurology
  87. Post-transcriptional regulons coordinate the initiation and resolution of inflammation
    Paul Anderson · 2009 · Nature reviews. Immunology
  88. Pathogenesis of postoperative adhesion formation
    Bart W.J. Hellebrekers, T. Kooistra · 2011 · British journal of surgery
  89. Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
    Sarah Skeoch, Ian N Bruce · 2015 · Nature Reviews Rheumatology
  90. The Influence of Innate and Adaptive Immune Responses on Atherosclerosis
    Joseph Lee Witztum, Andrew H. Lichtman · 2013 · Annual Review of Pathology Mechanisms of Disease
  91. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
    Institute of Medicine · 2010 · National Academies Press eBooks
  92. LDL cholesterol: controversies and future therapeutic directions
    Ridker, Paul M · 2014 · The Lancet
  93. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
    Stefan Blankenberg, Veikko V Salomaa, Nataliya Makarova, Francisco Ojeda, Philipp Sebastian Wild, Karl Johannes Lackner, Torben Jørgensen, Barbara Thorand, Annette Peters, Matthias A. Nauck et al. · 2016 · European Heart Journal
  94. Lipid management in patients with chronic kidney disease
    Charles Joseph Ferro, Patrick Barry Mark, Mehmet Kanbay, Pantelis A. Sarafidis, Gunnar Henrik Heine, Patrick Rossignol, Ziad A. Massy, Francesca Mallamaci, José Manuel Valdivielso, Jolanta Małyszko et al. · 2018 · Nature Reviews Nephrology
  95. Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques
    Steffen U. Eisenhardt, Jonathon Habersberger, Andrew James Murphy, Yung‐Chih Chen, Kevin J. Woollard, Nicole Bassler, Hongwei Qian, Constantin von zur Mühlen, Christoph Eugen Hagemeyer, Ingo Ahrens et al. · 2009 · Circulation Research
  96. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction
    Jaana Hartiala, Yi Ying Han, Qiong Jia, James R. Hilser, Pin Huang, Janet Gukasyan, William S. Schwartzman, Zhiheng Cai, Subarna Biswas, David‐Alexandre Trégouët et al. · 2020 · European Heart Journal
  97. Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults
    Priscilla Y. Hsue, Steven G. Deeks, Peter W. Hunt · 2012 · The Journal of Infectious Diseases
  98. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
    Paul M. Ridker · 2009 · Journal of Thrombosis and Haemostasis
  99. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
    Hae‐Young Lee, Jinho Shin, Gheun‐Ho Kim, Sungha Park, Sang‐Hyun Ihm, Hyeon Chang Kim, Kwang‐Il Kim, Ju Han Kim, Jang Hoon Lee, Jong‐Moo Park et al. · 2019 · Clinical Hypertension
  100. Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
    Goodarz Danaei, Mohammad Tavakkoli, Miguel Ángel Hernán · 2012 · American Journal of Epidemiology